Stay updated with breaking news from Morphosys Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MorphoSys (NASDAQ:MOR – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Monday, May 27th. Analysts expect MorphoSys to post earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last released its earnings results on Monday, April 29th. The company reported ($2.24) earnings […]
MorphoSys (NASDAQ:MOR – Get Free Report) will release its earnings data before the market opens on Monday, May 27th. Analysts expect MorphoSys to post earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last posted its quarterly earnings data on Monday, April 29th. The company reported ($2.24) EPS for the […]
MorphoSys (NASDAQ:MOR – Get Free Report) will be issuing its quarterly earnings data before the market opens on Monday, May 27th. Analysts expect the company to announce earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last posted its earnings results on Monday, April 29th. The company reported ($2.24) earnings […]
MorphoSys (NASDAQ:MOR – Get Free Report) and Graybug Vision (NASDAQ:GRAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations. Valuation & Earnings This table compares MorphoSys and Graybug […]
MorphoSys AG (NASDAQ:MOR – Get Free Report) has received a consensus recommendation of “Hold” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective among […]